首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1964467

体外诊断免疫诊断材料市场规模、份额和成长分析：按产品类型、应用和地区划分－2026-2033年产业预测

IVD Immunodiagnostic Raw Material Market Size, Share, and Growth Analysis, By Product Type (Core Reaction System, Signal System), By Application (Therapeutic Drug Monitoring, Oncology), By Region - Industry Forecast 2026-2033

出版日期: 2026年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2024年全球体外诊断免疫诊断原料市值为132.3亿美元，预计将从2025年的144.6亿美元成长到2033年的294.5亿美元。预测期（2026-2033年）的复合年增长率预计为9.3%。

体外诊断（IVD）免疫诊断原料市场的主要驱动力是临床、公共卫生和研究领域对可靠且扩充性的免疫检测试剂的需求不断增长。供应商致力于提供各种必要的组件，包括抗体、重组抗原、酵素以及用于检测感染疾病、肿瘤标记和自体免疫疾病的耗材。单株抗体生产和生物製造技术的进步显着推动了市场发展，提高了侧向流动检测和实验室检测的成本效益。此外，设计和製造流程的技术创新正在加速医院和诊所筛检计画的推广应用。人工智慧透过测试自动化和预测建模增强了品管，从而确保试剂品质和测试性能的一致性。

全球体外诊断免疫诊断原料市场驱动因素

全球体外诊断（IVD）免疫诊断原料市场的发展主要受免疫检测在包括临床检查室、医院和分散式检查环境在内的各种医疗机构中日益广泛的应用所驱动。这一趋势导致对高品质原料（如抗体、抗原、偶联物和特殊缓衝液）的持续需求。为提高检测灵敏度和重复性，製造商需要可靠的原料来源和标准化的生产流程。因此，供应商被迫提高产能、加强品管措施并投资于定製配方。这种持续的采购活动为供应商提供了稳定的收入来源，促进了创新，并推动了新检测方法的推出。最终，这将透过强大的供应链和产业内的伙伴关係来推动市场成长。

全球体外诊断免疫诊断原料市场限制因素

全球体外诊断（IVD）免疫诊断原料市场面临许多限制因素，主要源自于原料监管要求的复杂性和不断变化。这些严格的法规会延长研发週期，并增加供应商和製造商的合规成本，从而阻碍市场成长。对完整文件、批次可追溯性和必要认证的要求，需要投入大量资源用于验证、品管和法规遵从，这对于寻求进入或拓展市场的中小型供应商而言尤其不利。此外，遵守区域性标准以及持续的上市后监测也会降低营运柔软性，并延迟产品上市。因此，製造商往往优先考虑现有供应商而非创新新参与企业，阻碍了市场动态。

体外诊断免疫诊断原料的全球市场趋势

全球体外诊断（IVD）免疫诊断原料市场正经历着向就地检验解决方案的显着转变，製造商正专注于专为分散式检查环境设计的原料。这一趋势的特点是，对室温稳定配方、简化试剂混合物以及与卡盒式系统相容的组件的需求不断增长。供应商正努力提升产能，并与仪器製造商合作，确保工作流程的无缝衔接和产品品质的稳定性。此外，对小型化和冗余性的关注也增加了对能够实现小批量、高特异性检测的材料的需求。这推动了整个供应链的合作日益加强，可靠性、可自订性和物流柔软性对于满足各种照护现场应用不断变化的需求至关重要。

北美洲
- 我们
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场公司采取的策略
近期市场趋势
企业市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 按细分市场进行企业市占率分析
- 2023-2025年营收年比比较

主要企业简介

Abbott Laboratories
Siemens Healthineers
Roche Diagnostics
Bio-Rad Laboratories
Beckman Coulter
Thermo Fisher Scientific
Quidel Corporation
Agilent Technologies
Meridian Bioscience
Hologic
Ortho Clinical Diagnostics
Genentech
PerkinElmer
Becton, Dickinson and Company
Enzo Biochem
DiaSorin
Fujifilm Wako Pure Chemical Corporation
R-Biopharm AG
Scienion AG
The Binding Site Group

结论与建议

简介目录

Product Code: SQMIG35J2192

Global Ivd Immunodiagnostic Raw Material Market size was valued at USD 13.23 Billion in 2024 and is poised to grow from USD 14.46 Billion in 2025 to USD 29.45 Billion by 2033, growing at a CAGR of 9.3% during the forecast period (2026-2033).

The IVD immunodiagnostic raw material market is primarily driven by an increasing need for dependable and scalable reagents essential for immunoassays utilized in clinical, public health, and research environments. Suppliers are focused on delivering a range of necessary components such as antibodies, recombinant antigens, enzymes, and consumables, crucial for testing infectious diseases, oncology biomarkers, and autoimmune disorders. The market has evolved significantly through advancements in monoclonal antibody production and biomanufacturing, enhancing the affordability of lateral flow and lab-based assays. Furthermore, technological innovations in design and manufacturing processes are fostering broader adoption of screening programs in hospitals and clinics. Additionally, AI is augmenting quality control by automating inspections and predictive modeling, thereby ensuring robust reagent quality and assay performance consistency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ivd Immunodiagnostic Raw Material market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ivd Immunodiagnostic Raw Material Market Segments Analysis

Global ivd immunodiagnostic raw material market is segmented by product type, application and region. Based on product type, the market is segmented into Core Reaction System, Signal System, Carrier and Reaction Environment. Based on application, the market is segmented into Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Test, Autoimmune Disease and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ivd Immunodiagnostic Raw Material Market

The global IVD immunodiagnostic raw material market is driven by the rising use of immunoassays in various healthcare settings, including clinical laboratories, hospitals, and decentralized testing environments. This trend has led to a consistent demand for high-quality raw materials such as antibodies, antigens, conjugates, and specialized buffers. Manufacturers, aiming to enhance assay sensitivity and reproducibility, seek dependable sources of materials and standardized manufacturing processes. Consequently, suppliers are compelled to boost their production capacity, enhance quality control measures, and invest in custom formulations. This ongoing procurement supports stable supplier revenues, encourages innovation, and facilitates the introduction of new assays, ultimately fostering market growth through robust supply chains and collaborative industry partnerships.

Restraints in the Global Ivd Immunodiagnostic Raw Material Market

The Global IVD Immunodiagnostic Raw Material market faces significant constraints due to complex and ever-changing regulatory requirements surrounding raw materials. These stringent regulations can hinder market growth by lengthening development timelines and increasing compliance costs for both suppliers and manufacturers. The demands for thorough documentation, batch traceability, and necessary certifications necessitate the allocation of substantial resources toward validation, quality management, and regulatory affairs, which can particularly disadvantage smaller suppliers trying to enter or expand within the market. Furthermore, the need to adhere to varying regional standards and to conduct continuous postmarket surveillance diminishes operational flexibility, delays product launches, and frequently prompts manufacturers to favor established suppliers over innovative newcomers, ultimately stifling market dynamism.

Market Trends of the Global Ivd Immunodiagnostic Raw Material Market

The Global IVD Immunodiagnostic Raw Material market is experiencing a significant shift toward point-of-care testing solutions, prompting manufacturers to focus on raw materials specifically designed for decentralized testing environments. This trend is characterized by a rising demand for room-temperature-stable formulations, simplified reagent mixes, and components compatible with cartridge-based systems. Suppliers are responding by enhancing their production capabilities and engaging in collaborative development with device manufacturers to ensure seamless workflow integration and consistent product quality. Additionally, the emphasis on miniaturization and multiplexing is driving the need for materials that enable low-volume, high-specificity assays, thereby fostering greater collaboration across supply chains and emphasizing reliability, customization, and logistical flexibility to meet the evolving needs of diverse point-of-care applications.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
Value Chain Analysis

Global IVD Immunodiagnostic Raw Material Market Size by Product Type & CAGR (2026-2033)

Market Overview
Core Reaction System
Signal System
Carrier
Reaction Environment

Global IVD Immunodiagnostic Raw Material Market Size by Application & CAGR (2026-2033)

Market Overview
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease Test
Autoimmune Disease
Other

Global IVD Immunodiagnostic Raw Material Market Size & CAGR (2026-2033)

North America (Product Type, Application)
- US
- Canada
Europe (Product Type, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genentech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Wako Pure Chemical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R-Biopharm AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Scienion AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Binding Site Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments